CD274 and cancer: While CD274 expression is highly correlated with NRF2 signature score in LUAD cancer cells (Fig 6B), chromatin immunoprecipitation (ChIP) experiment in NRF2 activated human primary melanocytes confirmed direct binding of NRF2 to CD274 promoter, [44] suggesting that NRF2 may activate CD274 expression directly at transcription level.